Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer

The treatment of patients with stage IIIA (N2) non-small cell lung cancer (NSCLC) is one of the most challenging and controversial areas of thoracic oncology. This heterogeneous group is characterized by varying tumor size and location, the potential for involvement of surrounding structures, and ip...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Jennifer, Gillaspie, Erin A., Osmundson, Evan C., Horn, Leora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787144/
https://www.ncbi.nlm.nih.gov/pubmed/29410947
http://dx.doi.org/10.3389/fonc.2018.00005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787144/
https://www.ncbi.nlm.nih.gov/pubmed/29410947
http://dx.doi.org/10.3389/fonc.2018.00005

Ejemplares similares